PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting – A 2-year regional lipid clinic experience Georgia Anastasiou, George Liamis, Haralampos Milionis, Moses Elisaf, Eliza Christopoulou, Theodora Dimitriou, Evangelos N. Liberopoulos
The role of lipid-lowering treatment in the secondary prevention of ischemic stroke Eirini Konstantinidou, Konstantinos Tziomalos
Updated Guidelines of the Hellenic Society of Atherosclerosis for the diagnosis and treatment of dyslipidemia-2014 Moses Elisaf, Christos Pitsavos, Evangelos Liberopoulos, Kostas Tziomalos, Vasilios Athyros
The effect of simvastatin or its combination with ezetimibe on mean platelet volume in patients with primary dyslipidemia E. Moutzouri, A. Kei, M. Elisaf